醫藥合約包裝市場規模、佔有率和成長分析：按材料、類型、產品類型、最終用途、製劑類型、包裝形式和地區分類－2026年至2033年產業預測

2024 年全球藥品合約包裝市場價值為 70.6 億美元，預計到 2033 年將從 2025 年的 75.9 億美元成長至 135.5 億美元，預測期（2026-2033 年）的複合年成長率為 7.51%。

全球醫藥合約包裝市場正經歷顯著成長，這主要得益於新興市場對高品質包裝解決方案日益成長的需求以及企業向外包模式的策略轉變。製藥公司擴大選擇合約包裝服務，以最大限度地降低生產成本並提高營運效率。中小型製藥公司面臨包裝資源和專業知識匱乏以及資金限制等挑戰，因此與合約包裝供應商 (CPO) 建立合作關係成為一種極具吸引力的解決方案。這些合作關係能夠提供經濟高效的服務，有效應對產業通用面臨的挑戰。此外，全球製藥業的擴張也推動了市場的發展。外包包裝業務不僅能幫助企業取得先進技術，還能使其專注於核心業務，進而實現更快、更有效率的服務交付。

全球醫藥合約包裝市場促進因素

全球醫藥合約包裝市場的主要驅動力是製藥公司外包業務的日益成長。面對複雜的包裝要求、嚴格的監管標準以及成本效益的需求，許多製藥公司選擇將包裝業務外包給專業公司。這項策略決策使製藥公司能夠專注於藥物研發和行銷等核心業務，同時充分利用合約包裝供應商的專業知識。這些專業公司能夠提供創新且合規的包裝解決方案，滿足製藥業的特定需求，從而提高營運效率，並最終提升產品交付的整體品質。

全球醫藥合約包裝市場的限制因素

由於監管合規的複雜性，全球醫藥合約包裝市場面臨嚴峻挑戰。各國不斷變化的法規引入了各種各樣的包裝指南，涵蓋標籤要求、防篡改密封和耐久性標準等諸多方面。遵守這些嚴格的法規往往成本高昂，對於缺乏必要財力履行這些義務的中小型合約包裝公司而言，構成了一大障礙。此外，違規的潛在影響，例如產品召回和法律訴訟，可能會阻礙這些公司進入市場，並限制其成長和創新機會。

全球醫藥合約包裝市場趨勢

隨著環境問題日益受到關注，全球醫藥合約包裝市場正經歷著向永續包裝解決方案的顯著轉變。企業越來越傾向使用環保材料，例如生物分解性塑膠和可回收包裝材料，同時盡可能減少產生廢棄物的笨重設計。這種對永續性重視正在推動研發投入，使永續公司能夠創新並開發出既符合監管標準又滿足更廣泛環境目標的產品。在政府和消費者需求的驅動下，這一趨勢正成為推動產業發展的重要動力。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 價值鏈分析
• 價格分析
• 案例研究
• 監理情勢
• 技術評估

全球醫藥合約包裝市場規模：依材料分類

• 塑膠
• 紙張和紙板
• 金屬
• 鋁箔
• 其他

全球醫藥合約包裝市場規模：按類型分類

• 初級包裝
  • 瓶子
  • 管瓶
  • 安瓿
  • 其他
• 二級包裝
• 三級包裝

全球醫藥合約包裝市場規模：依產品類型分類

• 容器型
  • 非口服容器
  • 塑膠瓶
  • 特製包
  • 標籤
  • 其他

全球醫藥合約包裝市場規模：依最終用途分類

• 製藥公司
• 合約包裝業務
• 研究所

全球藥品合約包裝市場規模：依製劑類型分類

• 固體的
• 液體
• 其他

全球醫藥合約包裝市場規模：依包裝類型分類

• 注射器
• 小袋
• 盒子

全球醫藥合約包裝市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• AbbVie Inc.
• Amcor plc
• PCI Pharma Services
• Vetter Pharma International GmbH
• Gerresheimer AG
• Sharp Services LLC
• CCL Industries
• Nelipak Healthcare
• Aphena Pharma Solutions
• Thermo Fisher Scientific Inc.（Patheon）
• CordenPharma International
• Recipharm AB
• Daito Pharmaceutical Co., Ltd.
• West Pharmaceutical Services, Inc.
• Stevanato Group
• SGD Pharma
• BD
• Almac Group
• Korber AG
• Ecobliss Packaging Group

結論與建議

Global Pharmaceutical Contract Packaging Market size was valued at USD 7.06 Billion in 2024 and is poised to grow from USD 7.59 Billion in 2025 to USD 13.55 Billion by 2033, growing at a CAGR of 7.51% during the forecast period (2026-2033).

The global market for pharmaceutical contract packaging is witnessing significant growth driven by the rising demand for high-quality packaging solutions in emerging markets and a strategic shift towards outsourcing. Pharmaceutical companies are increasingly opting for contract packaging services to minimize manufacturing costs and enhance operational efficiencies. Small pharmaceutical firms face challenges such as limited packaging resources, expertise, and financial constraints, making partnerships with contract packaging organizations (CPOs) an attractive solution. These collaborations provide cost-effective services that address common industry challenges. Additionally, the expansion of the global pharmaceutical sector fuels the market, as outsourcing packaging not only offers access to advanced technologies but also enables companies to concentrate on core competencies, resulting in faster and more efficient service delivery.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Contract Packaging Market Segments Analysis

Global Pharmaceutical Contract Packaging Market is segmented by Material, Type, Product, End Use, Formulation Type, Packaging Type and region. Based on Material, the market is segmented into Plastics, Paper & Paperboard, Metal, Aluminum Foil and Others. Based on Type, the market is segmented into Primary Packaging, Secondary Packaging and Tertiary Packaging. Based on Product, the market is segmented into Container Types. Based on End Use, the market is segmented into Pharmaceutical Companies, Contract Packaging Organizations and Research Laboratories. Based on Formulation Type, the market is segmented into Solid, Liquid and Others. Based on Packaging Type, the market is segmented into Syringes, Pouches and Boxes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market is primarily driven by the increasing trend of outsourcing among pharmaceutical companies. As these organizations encounter complex packaging requirements, stringent regulatory standards, and the need for cost efficiency, many are choosing to delegate packaging tasks to specialized firms. This strategic decision enables pharmaceutical companies to concentrate on their core functions, such as drug development and marketing, while benefiting from the expertise of contract packaging providers. These specialists can deliver innovative and compliant packaging solutions tailored to meet the specific needs of the pharmaceutical industry, enhancing operational efficiency and ultimately improving overall product delivery.

Restraints in the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market faces notable challenges due to the complexities of regulatory compliance. The constantly evolving regulations across various countries introduce diverse packaging guidelines, which encompass aspects such as labeling requirements, tamper-proof seals, and durability standards. Adhering to these stringent regulations often incurs significant costs, posing a considerable barrier for small and medium-sized contract packaging firms that may lack the financial resources necessary to meet these obligations. Moreover, the potential consequences of non-compliance, including product recalls or legal actions, may discourage these companies from participating in the market, limiting their growth and innovation opportunities.

Market Trends of the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market is witnessing a significant shift towards sustainable packaging solutions as environmental concerns take center stage. Companies are increasingly exploring eco-friendly materials, such as biodegradable plastics and recyclable packaging, while minimizing bulky designs that contribute to waste. This growing emphasis on sustainability is catalyzing investments in research and development, enabling packaging firms to innovate and create products that align with both regulatory standards and broader environmental objectives. The drive for sustainable practices is further fueled by the demands of governments and consumers, solidifying this trend as a key influencer in the industry's evolution.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Pharmaceutical Contract Packaging Market Size by Material & CAGR (2026-2033)

• Market Overview
• Plastics
• Paper & Paperboard
• Metal
• Aluminum Foil
• Others

Global Pharmaceutical Contract Packaging Market Size by Type & CAGR (2026-2033)

• Market Overview
• Primary Packaging
  • Bottles
  • Vials
  • Ampoules
  • Others
• Secondary Packaging
• Tertiary Packaging

Global Pharmaceutical Contract Packaging Market Size by Product & CAGR (2026-2033)

• Market Overview
• Container Types
  • Parenteral Container
  • Plastic Bottle
  • Specialty Bags
  • Labels
  • Others

Global Pharmaceutical Contract Packaging Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Contract Packaging Organizations
• Research Laboratories

Global Pharmaceutical Contract Packaging Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Solid
• Liquid
• Others

Global Pharmaceutical Contract Packaging Market Size by Packaging Type & CAGR (2026-2033)

• Market Overview
• Syringes
• Pouches
• Boxes

Global Pharmaceutical Contract Packaging Market Size & CAGR (2026-2033)

• North America (Material, Type, Product, End Use, Formulation Type, Packaging Type)
  • US
  • Canada
• Europe (Material, Type, Product, End Use, Formulation Type, Packaging Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Type, Product, End Use, Formulation Type, Packaging Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Type, Product, End Use, Formulation Type, Packaging Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Type, Product, End Use, Formulation Type, Packaging Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CCL Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelipak Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aphena Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (Patheon)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CordenPharma International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daito Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korber AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecobliss Packaging Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations